Publications by authors named "M N Needle"

Claim this Profile
P
Phase Ib and Expansion Study of Gemcitabine, Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer.
Kimberly Perez, Anna M Chiarella, James M Cleary, Nora Horick, Colin Weekes, Michael Needle

Oncologist· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Q-TWiST Analysis of Tivozanib Versus Sorafenib in Patients With Advanced Renal Cell Carcinoma in the TIVO-3 Study.
Michael Szarek, Michael N Needle, Brian I Rini, Sumanta K Pal, David F McDermott

Clin Genitourin Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developmental impacts of the COVID-19 pandemic on young children: a conceptual model for research with integrated administrative data systems.
Heather L Rouse, Rebecca J Bulotsky Shearer, Sydney S Idzikowski, Amy Hawn Nelson, Mark Needle

Int J Popul Data Sci· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TiNivo: safety and efficacy of tivozanib-nivolumab combination therapy in patients with metastatic renal cell carcinoma.
L Albiges, P Barthélémy, M Gross-Goupil, S Negrier, M N Needle

Ann Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final Overall Survival Results from a Phase 3 Study to Compare Tivozanib to Sorafenib as Third- or Fourth-line Therapy in Subjects with Metastatic Renal Cell Carcinoma.
Sumanta K Pal, Bernard J Escudier, Michael B Atkins, Thomas E Hutson, Camillo Porta, Michael N Needle

Eur Urol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis